STOCK TITAN

Crown Holdings Inc. Form 4 Filings

CCK NYSE

Every Form 4 that Crown Holdings Inc. (CCK) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CCK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CCK filings page.

Rhea-AI Summary

Crown Holdings, Inc. reported that Gavin Gary M, its President - Americas Division, received a grant of 12,727 shares of restricted common stock on January 5, 2026 under the company’s 2022 Stock-Based Compensation Plan. These shares were awarded at a price of $0 per share, bringing his total directly held common shares to 38,943 after the grant.

The grant is split into time-based and performance-based portions. 4,382 time-vested restricted shares are scheduled to vest over three years: 1,461 shares on January 5, 2027, 1,461 shares on January 3, 2028, and 1,460 shares on January 3, 2029. In addition, 3,915 performance-based restricted shares are targeted to vest on January 3, 2029 based on Total Shareholder Return versus a defined peer group, and 4,430 performance-based restricted shares are targeted to vest on the same date based on Return on Invested Capital versus an ROIC target, with each performance tranche ultimately ranging from 0 to 200% of the target shares.

Rhea-AI Summary

Crown Holdings EVP & COO reported several equity transactions in company common stock dated January 5, 2026. The officer received 4,328 additional performance-based restricted shares at $0 following a total shareholder return outcome of 199% versus a defined peer group, increasing the payout on a prior award originally tied to 4,372 target shares. On the same date, 5,722 shares were transferred back to the company at $105.74 per share to cover tax withholding on vested restricted stock. The officer was also granted 22,339 new restricted shares under the 2022 Stock-Based Compensation Plan, including time-vested and performance-based tranches tied to total shareholder return and return on invested capital, with targeted vesting through January 3, 2029. Following these transactions, the officer directly beneficially owned 117,786 shares of Crown Holdings common stock.

Rhea-AI Summary

Crown Holdings reported insider equity transactions by its President of Transit Packaging on January 5, 2026. The officer received 3,168 additional performance-based restricted shares after the company’s total shareholder return versus a defined peer group produced a 199% payout on a prior 3,200-share target. The officer also had 2,737 shares transferred back to the company to cover taxes due on restricted stock vesting.

In addition, the officer was granted 11,069 shares of restricted common stock under the 2022 Stock-Based Compensation Plan. Of this grant, 3,811 time-vested shares are scheduled to vest over three years, and 6,? performance-based shares are targeted to vest on January 3, 2029 based on total shareholder return and return on invested capital measures, with final payouts ranging from 0% to 200% of their respective targets.

Rhea-AI Summary

Crown Holdings, Inc. executive reports equity award activity. On January 5, 2026, the company’s EVP & CAO reported vesting of 10,675 performance-based restricted shares of common stock at a stated price of $0. These additional shares were earned based on the company’s total shareholder return versus a defined peer group, which produced a 199% payout on an original performance target of 10,783 shares.

On the same date, the executive transferred 13,577 shares back to Crown Holdings at $105.74 per share to cover tax withholding related to the vesting. After these transactions, the executive directly owned 119,683 shares, with an additional 5,859 shares held indirectly through the company’s 401(k) plan as of December 31, 2025.

Rhea-AI Summary

Crown Holdings, Inc. reported equity award activity for its SVP, General Counsel & Secretary on January 5, 2026. The executive received 4,056 performance-based restricted shares that vested after the company’s total shareholder return versus a defined peer group produced a 199% payout on an original 2023 grant.

On the same date, 4,313 shares were surrendered to the company at $105.74 per share to cover tax withholding tied to restricted stock vesting. The executive was also granted 12,300 new restricted shares under the 2022 Stock-Based Compensation Plan, split between time-vested awards through 2029 and performance-based awards tied to future total shareholder return and return on invested capital outcomes.

Rhea-AI Summary

Crown Holdings Senior Vice President and CFO reported multiple equity transactions in company stock. On January 5, 2026, he received 4,456 additional performance-based restricted shares of common stock at $0, tied to a 2023 grant whose payout was based on the company’s total shareholder return versus a defined peer group, which produced a 199% payout. On the same date, 6,230 shares were transferred back to the company at $105.74 per share to cover tax withholding on vesting restricted stock. He was also granted 22,339 shares of restricted common stock under the 2022 Stock-Based Compensation Plan, a mix of time-vested and performance-based awards that are scheduled or targeted to vest through January 3, 2029 based on service, total shareholder return, and return on invested capital metrics. Following these transactions, he held 81,567 shares directly and 364 shares indirectly through a 401(k) plan as of the stated dates.

Rhea-AI Summary

Crown Holdings, Inc. President & CEO, who also serves as a director, reported several equity transactions in company stock dated January 5, 2026. The insider sold 29,024 shares of common stock at $105 per share under a Rule 10b5-1(c) trading plan adopted on May 20, 2025. On the same date, 27,130 performance-based restricted shares vested at no cost, reflecting a 199% payout versus a prior target grant tied to total shareholder return.

The insider transferred 34,336 shares back to the company to cover taxes related to vesting. In addition, the insider received a new grant of 85,386 shares of restricted common stock under the 2022 Stock-Based Compensation Plan, including time-vested and performance-based tranches with vesting targets through January 3, 2029. Following these transactions, the insider directly held 489,736 shares and indirectly held 778 shares in a 401(k) plan.

Rhea-AI Summary

Crown Holdings, Inc. reported an insider share sale by its President & CEO, who is also a director. On 12/18/2025, the reporting person sold 8,476 shares of Crown Holdings common stock at a price of $105.01 per share. After this transaction, the insider directly owned 440,580 shares of common stock.

The form indicates the transaction was carried out under a Rule 10b5-1(c) trading plan, which had an adoption date of 05/20/2025. In addition to the directly held shares, the insider also held 778 shares of Crown Holdings common stock in the company’s 401(k) plan as of September 30, 2025.

Rhea-AI Summary

Crown Holdings, Inc. reported an insider stock sale by an executive vice president and chief operating officer. On 12/16/2025, the officer sold 19,754 shares of common stock at a price of $101.02 per share. After this transaction, the insider directly beneficially owns 96,841 shares of Crown Holdings common stock.

Rhea-AI Summary

Crown Holdings (CCK) reported a director’s Form 4 showing an acquisition of 406 shares of deferred stock on 10/29/2025 (Transaction Code A). Each deferred stock share is economically equivalent to one share of common stock and becomes payable in cash after the individual ceases to be a Director. The filing lists a Price of Derivative Security of $98.756. Following the transaction, the number of derivative securities beneficially owned was 3,056, held directly.

Rhea-AI Summary

Crown Holdings (CCK) reported an insider transaction on a Form 4. A director acquired 406 shares of common stock on 10/29/2025 at a price of $98.756 per share. Following this transaction, the director beneficially owns 6,930 shares, held directly.

Rhea-AI Summary

Crown Holdings, Inc. (CCK) reported an insider transaction on a Form 4. A director acquired 406 shares of common stock on 10/29/2025 at a price of $98.756 per share. Following this transaction, the director beneficially owns 24,089 shares, held directly.

Rhea-AI Summary

Crown Holdings (CCK) disclosed an insider share purchase. On 10/29/2025, a company director acquired 406 shares of common stock at $98.756 per share. After this transaction, the director beneficially owns 6,017 shares, held directly. No derivative transactions were reported in this filing.

Rhea-AI Summary

Crown Holdings, Inc. (CCK) reported an insider transaction by a director. The filing shows the purchase of 406 shares of common stock at $98.756 on 10/29/2025.

Following the trade, the director beneficially owned 10,822 shares directly and 2,000 shares indirectly through The B Craig Owens Rev Trust U/A 1/25/08. This routine Form 4 updates the director’s reported holdings.

Rhea-AI Summary

Crown Holdings, Inc. (CCK) reported an insider transaction by a director. On 10/29/2025, the director acquired 406 shares of common stock at a price of $98.756 per share, according to a Form 4 filing.

After this transaction, the director’s direct holdings total 10,513 shares. No derivative securities were reported in this filing.

Rhea-AI Summary

Crown Holdings (CCK) reported an insider transaction: a director acquired 406 shares of common stock on 10/29/2025 at $98.756 per share. Following this transaction, the director’s directly held position stands at 16,739 shares.

This filing is a routine Form 4 disclosure of beneficial ownership changes. No derivative securities were reported in connection with this transaction.

Rhea-AI Summary

Crown Holdings (CCK) reported an insider transaction by a director. On 10/29/2025, the director acquired 406 shares of common stock at $98.756 per share. Following the trade, the director beneficially owned 11,690 shares directly and 16 shares indirectly through the Fearon Family Trust.

This Form 4 reflects a routine insider purchase and updated ownership balances.